ELA vs PFE · P/E 21, rev $155.2M vs P/E 20, rev $15.03B
Envela Corp (ELA) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Envela Corp (ELA) is a luxury goods company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ELA currently screens at market cap $158.1M and trailing P/E 21.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ELA and PFE stock pages for the full models.
Not investment advice.